~~<i id='9F1B2414D4'><strike id='9F1B2414D4'><tt id='9F1B2414D4'><pre id='9F1B2414D4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

author：explore 2025-09-27 09:59:03 - browse：9

The Food and Drug Administration on Thursday approved a gene therapy to treat people with hemophilia A, an inherited and rare bleeding disorder.

The treatment, called Roctavian, is made by BioMarin Pharmaceutical. It was first approved in Europe in August 2022.

Roctavian is a one-time therapy that, in clinical trials, dramatically reduced bleeding episodes and helped patients live without the blood transfusions used to treat the disease. The FDA first rejected Roctavian in 2020, asking BioMarin to amass more data on its safety and long-term durability, and then delayed its decision again to account for additional evidence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Adidas to release second batch of Yeezy sneakers after breakup with Ye

hotspot

focus

leisure time

explore

hotspot

knowledge

AdobeRoughlytwomillionAmericansareexpectedtoreceiveacancerdiagnosisthisyear.Somemembersofthisalready

WSS

Campaign finance charge dropped from case against Sam Bankman

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Trump PAC spent more than $40M on legal bills this year as his charges mount: Sources

American TikTok star stuck in Dubai for months following rental car altercation

FDA greenlights medical device to combat bladder issues

DeSantis wants to import drugs. Biden’s FDA blasted his plan

explore

explore

hotspot

Guidelines to prevent youth baseball injuries need more muscle

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

After affirmative action ruling, medical educators look to 'holistic review'

How the first Native Hawaiian psychiatrist helped diversify medicine

Bright Health sells Medicare Advantage business to Molina

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

In age of alternative facts, a scholarly course on calling out crap

Former Pear Therapeutics executives start new VC firm

Malaria cases in Florida and Texas: Here’s what you need to know

Vivek Ramaswamy made waves in the debate, much as in biotech

focus

Roche's accidental data boosts hopes for anti

'Weather

Wegovy improves function in certain heart failure patients

How the drug

Can U.S. cancer drug shortages be fixed?

American TikTok star stuck in Dubai for months following rental car altercation

leisure time

explore

hotspot

knowledge